ethyl 2-benzyl-3-(tert-butylsulfinyl)propionate | 114469-31-7

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: ethyl 2-benzyl-3-(tert-butylsulfinyl)propionate
• 英文别名: 2-benzyl-3-tert.-butylsulphinyl-propionic acid ethyl ester；ethyl (RS)-alpha-[[(RS)-t-butylsulphinyl]methyl]hydrocinnamate；ethyl 2-benzyl-3-tert-butylsulfinylpropanoate
• CAS: 114469-31-7
• 化学式: C₁₆H₂₄O₃S
• 分子量: 296.431
• InChiKey: CJECJKHXCPYDKL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  20
• 可旋转键数：
  8
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  62.6
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  ethyl 2-benzyl-3-(tert-butylsulfinyl)propionate 在 盐酸 、 sodium hydroxide 作用下， 以 甲醇 、 水 为溶剂， 生成 2-benzyl-3-(tert-butylsulfinyl)propionic acid
  参考文献：
  名称：

  Antihypertensive 5-amino-4-hydroxyvaleryl derivatives substituted by

  摘要：

  公式为##STR1##的化合物，其中R.sub.1代表由硫、亚硫氧或磺酰基取代的酰基，A代表一个可选择地N-烷基化的α-氨基酸残基，该残基在N-端与R.sub.1和C-端与基团--NR.sub.2--键合，R.sub.2代表氢或较低的烷基，R.sub.3代表氢、较低的烷基、可选择地醚化或酯化的羟基较低烷基、环烷基、环烷基较低烷基、双环烷基较低烷基、三环烷基较低烷基、芳基或芳基较低烷基，R.sub.4代表羟基或醚化或酯化的羟基，R.sub.5代表较低的烷基、可选择地醚化或酯化的羟基较低烷基、环烷基、环烷基较低烷基、双环烷基、双环烷基较低烷基、三环烷基、三环烷基较低烷基、芳基、芳基较低烷基、可选择地取代的氨基甲酰、可选择地取代的氨基、可选择地取代的羟基、可选择地取代的巯基、亚硫

  公开号：

  US04758584A1
• 作为产物：
  描述：

  乙基2-苄基丙烯酸酯 在 sodium hydride 、 间氯过氧苯甲酸 作用下， 以 乙醇 、 二氯甲烷 为溶剂， 反应 61.0h， 生成 ethyl 2-benzyl-3-(tert-butylsulfinyl)propionate
  参考文献：
  名称：

  Synthesis and biological activity of some transition-state inhibitors of human renin

  摘要：

  A series of renin inhibitors containing the dipeptide transition state mimics (2S,4S,5S)-5-amino-4-hydroxy-2-isopropyl-7-methyloctanoic acid (Leu (OH)/Val) and (2S,4S,5S)-5-amino-4-hydroxy-2-isopropyl-6-cyclohexylhexanoic acid (CHa /(OH)/Val) was prepared. A structure-activity study with Boc-Phe-His-Leu (OH)/Val-Ile-His-NH2 (8a) as starting material led to N-[(2S)-2-[(tert-butylsulfonyl)methyl]-3-phenylpropionyl]-His-Cha (OH)/ Val- NHC4H9-n (8i) which has the length of a tetrapeptide and contains only one natural amino acid. Compound 8i had an IC50 of 2 x 10(-9) M against human renin and showed high enzyme specificity; IC50 values against the related aspartic proteinases pepsin and cathepsin D were (8 x 10(-6) and 3 x 10(-6) M, respectively). In salt-depleted marmosets, 8i inhibited plasma renin activity PRA and lowered blood pressure for up to 2 h after oral administration of a dose of 10 mg/kg.

  DOI：

  10.1021/jm00117a027

文献信息

• Antihypertensive 5-amino-4-hydroxyvaleryl derivatives substituted by
  申请人：Ciba-Geigy Corporation

  公开号：US04758584A1

  公开（公告）日：1988-07-19

  Compounds of the formula ##STR1## in which R.sub.1 represents acyl substituted by a thio, sulphinyl or sulphonyl group, A represents an optionally N-alkylated .alpha.-amino acid residue that is bonded N-terminally to R.sub.1 and C-terminally to the group --NR.sub.2 --, R.sub.2 represents hydrogen or lower alkyl, R.sub.3 represents hydrogen, lower alkyl, optionally etherified or esterified hydroxy-lower alkyl, cycloalkyl, cycloalkyl-lower alkyl, bicycloalkyl-lower alkyl, tricycloalkyl-lower alkyl, aryl or aryl-lower alkyl, R.sub.4 represents hydroxy or etherified or esterified hydroxy, R.sub.5 represents lower alkyl, optionally etherified or esterified hydroxy-lower alkyl, cycloalkyl, cycloalkyl-lower alkyl, bicycloalkyl, bicycloalkyl-lower alkyl, tricycloalkyl, tricycloalkyl-lower alkyl, aryl, aryl-lower alkyl, optionally substituted carbamoyl, optionally substituted amino, optionally substituted hydroxy, optionally substituted mercapto, sulphinyl or sulphonyl, and R.sub.6 represents substituted amino, and salts of such compounds having salt-forming groups, inhibit the blood pressure-increasing action of the enzyme renin and can be used as anti-hypertensives.

  公式为##STR1##的化合物，其中R.sub.1代表由硫、亚硫氧或磺酰基取代的酰基，A代表一个可选择地N-烷基化的α-氨基酸残基，该残基在N-端与R.sub.1和C-端与基团--NR.sub.2--键合，R.sub.2代表氢或较低的烷基，R.sub.3代表氢、较低的烷基、可选择地醚化或酯化的羟基较低烷基、环烷基、环烷基较低烷基、双环烷基较低烷基、三环烷基较低烷基、芳基或芳基较低烷基，R.sub.4代表羟基或醚化或酯化的羟基，R.sub.5代表较低的烷基、可选择地醚化或酯化的羟基较低烷基、环烷基、环烷基较低烷基、双环烷基、双环烷基较低烷基、三环烷基、三环烷基较低烷基、芳基、芳基较低烷基、可选择地取代的氨基甲酰、可选择地取代的氨基、可选择地取代的羟基、可选择地取代的巯基、亚硫
• Amino acid derivatives
  申请人：Hoffmann-La Roche Inc.

  公开号：US05256645A1

  公开（公告）日：1993-10-26

  The compounds of the formula ##STR1## wherein A, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are as set forth above, are described. The compounds of formula I have an inhibitory activity on the natural enzyme renin and can accordingly be used in the form of pharmaceutical preparations for the control or prevention of high blood pressure and cardiac insufficiency.

  公式为##STR1##其中A，R.sup.1，R.sup.2，R.sup.3，R.sup.4，R.sup.5和R.sup.6如上所述的化合物已被描述。公式I的化合物具有对天然酶肾素的抑制活性，因此可以用于制备药物以控制或预防高血压和心脏不全。
• BUHLMAYER, PETER;CASELLI, ANTHONY;FUHRER, WALTER;GOSCHKE, RICHARD;RASETTI+, J. MED. CHEM., 31,(1988) N 9, C. 1839-1846
  作者：BUHLMAYER, PETER、CASELLI, ANTHONY、FUHRER, WALTER、GOSCHKE, RICHARD、RASETTI+

  DOI：——

  日期：——
• US4758584A
  申请人：——

  公开号：US4758584A

  公开（公告）日：1988-07-19
• US4889869A
  申请人：——

  公开号：US4889869A

  公开（公告）日：1989-12-26